Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Adaptive DBS for PD

NCT: NCT07635823 · RECRUITING

NCT IDNCT07635823
StatusRECRUITING
Start Date2026-05-16
Completion2027-09-30
SponsorBeijing Pins Medical Co., Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to evaluate the efficacy and safety of an adaptive deep brain stimulation (aDBS) system for managing Parkinson's disease symptoms. Researchers will compare closed-loop stimulation (which automatically adjusts therapy using real-time brain signals and sleep monitoring) against traditional continuous stimulation (fixed settings) in a randomized, double-blind, crossover study. Participants will undergo surgical implantation of PINS Medical's G1010R neurostimulator, followed by alternating treatment phases where each patient experiences both aDBS and conventional open-loop stimulation modes. Outcomes will assess improvements in without troublesome dyskinesia daily time, motor symptoms (e.g., tremors, rigidity), quality of life, and sleep quality across both therapy periods.

Frequently Asked Questions

What is Adaptive DBS for PD?

Adaptive DBS for PD is a clinical trial registered under NCT07635823. Current status: RECRUITING.

What is the status of NCT07635823?

The current status of NCT07635823 (Adaptive DBS for PD) is: RECRUITING.

When did Adaptive DBS for PD start?

Adaptive DBS for PD started on 2026-05-16.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.